Dublin, Jan. 26, 2017 -- Research and Markets has announced the addition of the "Neurostimulation Devices Market Analysis & Trends - Product, Application - Forecast to 2025" report to their offering.
The Global Neurostimulation Devices Market is poised to grow at a CAGR of around 15.3% over the next decade to reach approximately $18.99 billion by 2025.
Some of the prominent trends that the market is witnessing include increased spending in R&D and huge growth potential from emerging nations.
This industry report analyzes the global markets for Neurostimulation Devices across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
Based on Application the market is categorized into Pain management, Parkinson's Disease, Essential tremor, Gastroparesis, Epilepsy, Depression, Urinary and fecal incontinence, Dystonia and Other Applications.
Depending on the Product the market is segmented by Spinal cord stimulators, Deep brain stimulators, Vagus nerve stimulators, Sacral nerve stimulators and Gastric electric stimulators.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Huge growth potential from emerging nations
3.1.2 Increased spending in R&D
3.1.3 Recent Technological advancements in Neurostimulation Devices
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Neurostimulation Devices Market, By Application
4.1 Pain management
4.2 Parkinson's Disease
4.3 Essential tremor
4.4 Gastroparesis
4.5 Epilepsy
4.6 Depression
4.7 Urinary and fecal incontinence
4.8 Dystonia
4.9 Other Applications
5 Neurostimulation Devices Market, By Product
5.1 Spinal cord stimulators
5.2 Deep brain stimulators
5.3 Vagus nerve stimulators
5.4 Sacral nerve stimulators
5.5 Gastric electric stimulators
6 Neurostimulation Devices Market, By Geography
7 Key Player Activities
7.1 Mergers & Acquisitions
7.2 Partnerships, Joint Venture's, Collaborations and Agreements
7.3 Product Launch & Expansions
7.4 Other Activities
8 Leading Companies
8.1 Boston Scientific Corporation
8.2 Codman & Shurtleff's
8.3 Cyberonics
8.4 IntraPace
8.5 Medtronic
8.6 Neuronetics, Inc
8.8 Nevro Corporation
8.8 St. Jude Medical
8.9 Uroplasty
For more information about this report visit http://www.researchandmarkets.com/research/2kt5nh/neurostimulation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



